• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NUZ

NEURIZON THERAPEUTICS LIMITED - Charts / Financials

2.38% ! 8.2¢
Market Cap $59.54M  !
Healthcare Biotechnology
Add to My Watchlist

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight arrow Created with Sketch.

NEURIZON NUZ-001 OLE CONFIRMS SAFETY SIGNALS
refresh Created with Sketch. REFRESH
Last update - 15.31pm 14/04/2026 (20 minute delay) ?
Day
Open 8.2¢   Day High 8.5¢   Day Low 8.2¢
Daily Volume 303997
Bids   Sellers
Number Price Volume   Number Price Volume
0 8.2¢ 17800   0 8.4¢ 22500

Directors & Senior Management

Dr. Angela Frimberger Veterinary Clinical Advisory Board Chair
Dr. Barbara Kitchell Veterinary Advisory Board Member
Dr. Chris Freitag Chief Medical Advisor
Dr. Christian Schirvel Veterinary Clinical Advisory Board Member
Mr. Dan O’Connell Chief Financial Officer
Ms. Fiona Milner General Manager of Epichem Pty Ltd
Dr. Gary Pitt Head of Chemistry
Dr. Herbert Brinkman Head of Manufacturing
Dr. James Rixson Head of Production
Dr. Jeffrey M. Brown Chief Scientific Advisor
Mr. John Clark Chief Operating Officer
Ms. Justine Conway Board Observer
Dr. Kathryn MacFarlane Non-Executive Director
Ms. Lidija Damjanovic Head of Marketing & Corporate Affairs
Mr. Marcus Paul Hughes Non-Executive Director
Dr. Martin Engel Head of Business Development
Dr. Michael Thurn Non-Executive Director
Dr. Nicky Wallis Chief Scientific Officer
Mr. Sergio Duchini Executive Chairman
Mr. Stefan Ross Company Secretary

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
8.2¢ 		Change
-0.002(2.38%) 		Mkt cap ! $59.54M
Open High Low Volume
8.2¢ 8.5¢ 8.2¢ 303.9K

Buyers (Bids)

Vol. Price($)
17800 8.2¢
 

Sellers (Offers)

Price($) Vol.
8.4¢ 22500
Last trade - 15.31pm 14/04/2026 (20 minute delay) ?

Top Stories

HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre. In this segment, we wrap up the stocks and company announcements you were watching this week on Australia’s #1 finance website. Let’s get straight into it, star...
US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27 AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and founder and managing director Hartley Atkinson believes it’s only going to get better as the growing Oz-based multinational pharmaceutical compan...
Federal gov't pours cold water on QLD's Taroom fast track call being called a 'generational opportunity' The Queensland government says the Taroom Trough should receive special support due to its potential to provide fuel security for Australia.
Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk about Trump’s big national speech and its many Trumpian victory calls, and flinch at the Aussie m...
Introducing Prairie Lithium: Saskatchewan's permitted lithium project ready to scale We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's bullish note on lithium.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.